Treatment of metastatic renal cell carcinoma and renal pelvic cancer
Author:
Publisher
Springer Science and Business Media LLC
Subject
Physiology (medical),Nephrology,Physiology
Link
http://link.springer.com/content/pdf/10.1007/s10157-011-0438-9.pdf
Reference65 articles.
1. Knox M, Colli JL. Characterizing changes in kidney and renal pelvis cancer incidence from 1998 to 2006 in the United States. Int Urol Nephrol. 2011. doi: 10.1007/s11255-010-9827-3 .
2. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74–108.
3. Chow WH, Dong LM, Devesa SS. Epidemiology and risk factors for kidney cancer. Nat Rev Urol. 2010;7:245–57.
4. Guinan PD, Vogelzang NJ, Fregman AM, Chmiel JS, Sylvester JL, Sener SF, et al. Renal cell carcinoma: tumor size, stage and survival. Members of the Cancer incidence and End Results Committee. J Urol. 1995;153:901–3.
5. Parton M, Gore M, Eisen T. Role of cytokine therapy in 2006 and beyond for metastatic renal cell cancer. J Clin Oncol. 2006;24:5584–92.
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Fisetin enhances cisplatin sensitivity in renal cell carcinoma via the CDK6/PI3K/Akt/mTOR signaling pathway;Oncology Letters;2024-02-20
2. Atractylenolide I Enhances Cisplatin Sensitivity in Renal Cell Carcinoma through Activation of FOXO1/ATG5 Pathway-Regulated Autophagy Hyperactivation;J BIOL REG HOMEOS AG;2023
3. Dynamic Predictive Models with Visualized Machine Learning for Assessing the Risk of Lung Metastasis in Kidney Cancer Patients;Journal of Oncology;2022-10-14
4. Lefty A is involved in sunitinib resistance of renal cell carcinoma cells via regulation of IL-8;Biological Chemistry;2021-08-09
5. TBOPP enhances the anticancer effect of cisplatin by inhibiting DOCK1 in renal cell carcinoma;Molecular Medicine Reports;2020-06-16
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3